PATH | VRL
Menu

Effectiveness of a Monovalent Rotavirus Vaccine in Infants in Malawi After Programmatic Roll-Out: An Observational and Case-Control Study

This article, published in The Lancet Infectious Diseases, reports on a study to evaluate the effectiveness of a monovalent rotavirus vaccine in infants in Malawi. The authors found that the vaccine was 64 percent effective in preventing hospitalization for rotavirus diarrhea among vaccinated infants and children. They also concluded that the introduction of rotavirus vaccine in Malawi has significantly decreased the rate of rotavirus hospitalizations among infants.

Author: Bar-Zeev N, Kapanda L, Tate JE, et al.

Published: 2015

» Visit web page (English)

(Located at www.thelancet.com)

Citation: Bar-Zeev N, Kapanda L, Tate JE, et al. Effectiveness of a Monovalent Rotavirus Vaccine in Infants in Malawi After Programmatic Roll-Out: An Observational and Case-Control Study. The Lancet Infectious Diseases. 2015;Early Online Publication.

Resource types: Peer-reviewed journal

Diseases/vaccines: Rotavirus

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: Africa